Mexoprofen

Mexoprofen

SCHEMBL2111806

CC(C(=O)O)c1ccc([C@H]2CCCC[C@@H]2C)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 13/20 0.47
PTGS2 P35354 13/20 0.47
MT-CO1 P00395 1/20 0.47
MT-CO2 P00403 1/20 0.47
APP P05067 1/20 0.46
OPRK1 P41145 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
EPHX1 P07099 1/20 0.44
LMNA P02545 2/20 0.42
CYP2C9 P11712 2/20 0.42
AKR1C3 P42330 2/20 0.42
CXCR1 P25024 2/20 0.42
CXCR2 P25025 2/20 0.42
ALB P02768 1/20 0.42
ESR1 P03372 1/20 0.42
ALOX5 P09917 1/20 0.42
RARB P10826 1/20 0.42
ADRB3 P13945 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mexoprofen SCHEMBL11858696 1.00 PTGS1 (0.47) PTGS1PTGS2MT-CO1MT-CO2APP
SCHEMBL7545064 0.83 PTGS1 (0.58) PTGS1PTGS2MT-CO1MT-CO2APP
SCHEMBL7545062 0.83 PTGS1 (0.58) PTGS1PTGS2MT-CO1MT-CO2APP
SCHEMBL11468007 0.80 APP (0.64) PTGS1PTGS2MT-CO1MT-CO2APP
SCHEMBL28874197 0.80 PTGS1 (0.43) PTGS1PTGS2MT-CO1MT-CO2APP
Hexaprofen SCHEMBL2111016 0.79 APP (0.67) PTGS1PTGS2MT-CO1MT-CO2APP
SCHEMBL11805930 0.78 RAB9A (0.42) TSHRKCNQ3KCNQ2
SCHEMBL2436189 0.76 APP (0.56) PTGS1PTGS2MT-CO1MT-CO2APP
SCHEMBL11805124 0.74 ACHE (0.35) KMT2AKCNQ3KCNQ2
SCHEMBL11803963 0.73 KMT2A (0.43) HTTKMT2AEPHX1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
US-20060252938-A1 Process for the separation of palladium catalyst from crude reaction mixtures of aryl acetic acids obtained by carbonylation BASF AKTIENGESELLSCHAFT (DE) 2006-11-09 US claimed
WO-2004096747-A1 PROCESS FOR THE SEPARATION OF PALLADIUM CATALYST FROM CRUDE REACTION MIXTURES OF ARYL ACETIC ACIDS OBTAINED BY CARBONYLATION BASF AKTIENGESELLSCHAFT (DE) 2004-11-11 WO claimed
EP-1336602-A1 Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases Scaramuzzino, Giovanni (IT) 2003-08-20 EP claimed
WO-1996026177-A1 PROCESS FOR PREPARING ARYLACETIC ACID AND ARYLPROPIONIC ACID DERIVATIVES HOECHST CELANESE CORPORATION (US) 1996-08-29 WO claimed
EP-0672029-A1 SELECTIVE PRECIPITATION OF $g(a)-ARYL CARBOXYLIC ACID SALTS HOECHST CELANESE CORPORATION (US) 1995-09-20 EP claimed
US-5380867-A Selective precipitation of α-aryl carboxylic acid salts HOECHST CELANESE CORPORATION (US) 1995-01-10 US claimed
WO-1994012451-A1 SELECTIVE PRECIPITATION OF α-ARYL CARBOXYLIC ACID SALTS HOECHST CELANESE CORPORATION (US) 1994-06-09 WO claimed
EP-0274146-B1 PROCESS FOR THE PREPARATION OF 2-ARYLPROPIONIC ACIDS GIST-BROCADES N.V. (NL) 1992-04-01 EP claimed
EP-0205215-B1 PROCESS FOR THE PREPARATION OF 2-ARYLPROPIONIC ACIDS GIST-BROCADES N.V. (NL) 1990-08-08 EP claimed
US-4886750-A STEREOSELECTIVE HYDROLYSIS USING MICROORGANISMS GIST-BROCADES N.V. (NL) 1989-12-12 US claimed
EP-0274146-A1 Process for the preparation of 2-arylpropionic acids GIST-BROCADES N.V. (NL) 1988-07-13 EP claimed
CN-87100031-A The preparation method of 2-arylpropionic acid 1987-09-09 CN claimed
EP-0233656-A1 Microbial esterase and process for the preparation of 2-arylpropionic acids GIST-BROCADES N.V. (NL) 1987-08-26 EP claimed
EP-0205215-A2 Process for the preparation of 2-arylpropionic acids GIST-BROCADES N.V. (NL) 1986-12-17 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252938-A1 Process for the separation of palladium catalyst from crude reaction mixtures of aryl acetic acids obtained by carbonylation PDK2, PDHA2, ADH5 PTGS1 2612/4885PTGS2 1669/4885MT-CO1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.